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Background: Studies on data collection and quality of care in Italian family medicine are lacking. The aim of this
study was to assess the completeness of data collection of patients with diabetes in a large sample of family
physicians in the province of Verona, Veneto region, a benchmark for the Italian National Health System.
Methods: We extracted the data on all the patients with diabetes from the electronic health records of 270
family physicians in 2006 and 2009. We reported the percentage of patients with data recorded for 12 indicators
of performance derived from the National Institute for Clinical Excellence diabetes guidelines. Secondarily, we
assessed quality of care using the Q-score (the lower the score, the greater the risk of cardiovascular events).
Results: Patients with diabetes were 18,507 in 2006 and 20,744 in 2009, and the percentage of patients registered as
having diabetes was 4.9% and 5.4% of the total population, respectively (p < 0.001). Data collection improved for all
the indicators between 2006 and 2009 but the performance was still low at the end of the study period: patients with
no data recorded were 42% in 2006 and 32% in 2009, while patients with data recorded for ≥5 indicators were 9% in
2006 and 17% in 2009. The Q-score improved (mean ± SD, 20.7 ± 3.0 in 2006 vs 21.3 ± 3.6 in 2009, p < 0.001) but most
patients were at increased risk of cardiovascular events in both years (Q-score ≤ 20).
Conclusions: We documented an improvement in data collection and quality of care for patients with diabetes during
the study period. Nonetheless, data collection was still unsatisfactory in comparison with international benchmarks in
2009. Structural interventions in the organization of family medicine, which have not been implemented since
the study period, should be prioritised in Italy.
Keywords: Diabetes, Family medicine, Data collection, Q-score, Performance, Primary careBackground
Beyond its clinical and social burden, diabetes also has
a dramatic impact on the consumption of economic
resources [1, 2]. Several studies showed that evidence-
based management of diabetes and good quality of
patient care can contribute to slow disease progression,
reduce the economic costs and achieve better patients’
outcomes [3–5].
A complete and proper collection of patients’ data is the
basis for an effective set up of clinical improvement strat-
egies [6]. Table 1 reports data on the clinical management* Correspondence: alessandro.marcon@univr.it
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Public Health, University of Verona, c/o Istituti Biologici II, Strada Le Grazie 8,
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Full list of author information is available at the end of the article
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(http://creativecommons.org/publicdomain/zeof diabetes derived from national or local surveys in Italy,
UK and Australia during the years 2003–2009 [7–11]. The
United Kingdom (UK) diabetes national audit program
has become an international benchmark, since it has
covered the whole country for a long period and it has
been carried out regularly [7]. All currently available
data about diabetes management in Italian family medicine
were collected through surveys on primary care physicians
involved on a voluntary basis. For this reason, findings
from these studies may depend on self-selection of
particularly careful physicians, motivated to improve
their performance.
In Italy a mixed public-private system provides healthcare.
The public part, the National Health System, is adminis-
trated on a regional basis and responsibility for healthcarele is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
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healthcare trust, LHT). Italian citizens receive healthcare
services from the LHTs, and primary and secondary diabetes
healthcare are ensured for free.
In the province of Verona, in Northern Italy (Additional
file 1: Figure S1), one LHT (Azienda Ulss 9 Scaligera)
provides services to about 900,000 inhabitants http://
statistica.regione.veneto.it/banche_dati_societa_residenti_
eta_sesso.jsp. Several studies have documented that the
prevalence of diabetes in the area of Verona is about
5.5–5.9% [5, 12, 13]. In this area, on initiative of the major
family physicians’ Union (FIMMG Verona), a central data-
bank was implemented during 2008 in order to remotely
collect clinical performance data from professional data-
bases of members of the Union. These data were used to
address Union’s policy towards the economic agreements
with the LHTs. Between 2006 and 2009 about 650 family
physicians were active in the province of Verona; 270 (42%)
of them were FIMMG members and they were all con-
nected to the databank. These family physicians received
benefits coming from economy of scale in their purchases
of professional equipment and, mostly, from remote real-
time assistance on auditing their clinical or prescribing per-
formance targets, which were linked to economic incen-
tives. The central databank was actively collecting data
until 2010, when it was finally switched off. During the
2006–2009 time period no economic agreement on family
physicians’ clinical performance on diabetes was active.
The primary aim of this study is to assess data collec-
tion for diabetes in family medicine in the province of
Verona in 2006 and 2009 and to compare it with avail-
able data from national and international studies. The
secondary aim is to explore the quality of care using the
Q-score, a score predicting the development of cardio-
vascular events.Methods
Study design
All 270 family physicians working in the province of
Verona, who adhered to the databank in 2008, were
included in this study. The data on all their patients
with diabetes, which had been recorded by the family
physicians during every day real-life practice in their
professional electronic databases, were collected for
2006 and 2009 after irreversible anonymization.
Patients with diabetes were identified considering
either a reported classification of diabetes according
to the International Classification of Diseases 9th
edition, or an exemption from health spending from
diabetes, or “diabetes” as free text. An analysis of data
consistency and data entry quality had been performed
when each family physician joined the databank, but
there was no standardisation of diabetes definition.Data collection performance indicators
Indicators of performance were chosen ex-post from the
National Institute for Clinical Excellence (NICE) 2005
diabetes guidelines, which are also the reference in the
UK diabetes national audit program [7, 14, 15]. These
guidelines were selected as follows. Among 21 diabetes
clinical guidelines available in 2006, 3 guidelines reported
performance indicators (see Additional file 1: Table S1).
Three independent reviewers rated these guidelines ac-
cording to a score obtained by a three-item checklist [16].
The guidelines with the highest mean score were selected.
Among the indicators available in the NICE guidelines,
we pragmatically selected the 12 indicators with data avail-
able in our study: blood pressure, body mass index (BMI),
smoking habits, total cholesterol, low-density lipoprotein
(LDL) cholesterol, microalbuminuria (MA), creatinine,
creatinine clearance, glycated haemoglobin, foot exam-
ination, eye examination and urine test. For each indi-
cator, we collected data on the number of registrations
per year in the family physicians’ electronic health records.
According to the guidelines, at least 1 registration per year
had to be recorded for each indicator to be at target
performance, except for blood pressure and glycated
haemoglobin, where at least 4 registrations per year were
required. Data on the measured values were available only
for the last examination registered.Quality of diabetes care score
In order to assess the quality of diabetes care, we com-
puted the Q-score, which predicts the development of
cardiovascular events. The Q-score was developed and
validated in a sample of the Italian population [3]. It ranges
between 0 and 40 (lowest to highest quality of care). It has
been reported that a Q-score ≤ 10 predicts an 89% greater
risk of long-term cardiovascular events as compared to a
score > 20 [3]. Briefly, a 0 to 10 score was assigned to every
patient with available information on each of 4 dimensions:
glycated haemoglobin, blood pressure, low-density lipopro-
tein (LDL) and microalbuminuria (MA). For each dimen-
sion, the assigned score reflected both the values of the
indicators measured at the last examination registered and
the presence/absence of at least one examination in the
index year. Patients with incomplete information or non-
valid data on one or more of the above indicators were
excluded from this assessment.Statistical analysis
Categorical variables were described as percentages, and
quantitative variables were summarised as mean ± SD or
median with interquartile range (1st and 3rd quartiles).
Temporal variations in patients’ and family physicians’
characteristics were tested by the Wilcoxon matched-pairs
signed-ranks test and McNemar’s exact test as appropriate.
Table 2 Demographic information and therapeutic regimen of
patients with diabetes in 2006 and 2009a
2006
(N = 18,507)
2009
(N = 20,744)
p-value
Demographic
information
Male sex 9797 (53) 10,948 (53) 0.818
Age (yr) 66.1 ± 13.7 67.8 ± 13.8 <0.001
Antidiabetic
therapy
Metformin 2893 (16) 6989 (34) <0.001
Other hypoglycaemic
agent
413 (2) 1348 (6) <0.001
Insulin (or analogue) 1994 (11) 3099 (15) <0.001
Any in the category 4771 (26) 9762 (47) <0.001
Additional
therapy
Statin 4040 (22) 7202 (35) <0.001
Acetylsalicylic acid
or other platelet
aggregation inhibitor
4951 (27) 7974 (38) <0.001
Renin-angiotensin
system modifier
8255 (45) 11,815 (57) <0.001
Any in the category 10,097 (55) 14,610 (70) <0.001
aNumber (percentage) or mean ± SD reported
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the first analysis, which illustrates the completeness of
family physicians’ electronic databases, we reported the
percentage of family physicians with 0%, ≥50% (between
50% and 100%) and ≥75% (between 75% and 100%) of their
patients with data recorded for each indicator. In the
second analysis, we considered family physicians as a
single group, and we reported the percentage of patients
with recorded data for each indicator, as well as the distri-
bution of the patients according to the number of indica-
tors recorded. This latter analysis focuses on patients,
rather than on family physicians, and it shows the propor-
tion of the overall population of patients with satisfactory
data registration.
We tested temporal variations in performance using
population-averaged, generalised estimating equations
(GEEs) for a binomial outcome with logarithmic link,
with family physicians identified as the clustering factor,
and year (2009 versus 2006) as the main independent
variable. These models provided crude risk ratios (RR).
Adjusted RRs were obtained after additional adjustment
for patients’ characteristics that could influence a family
physician’s propensity to record data: sex, age (categorised
as <40, 40–59, 60–79, ≥80 years to account for possible
non-linear associations), antidiabetic therapy (1 =metformin
or other hypoglycaemic agent (alone); 2 = insulin or
analogue; 0 = none of them) as an indicator of disease
severity, and additional therapy (1 = at least one among
statin, acetylsalicylic acid or other platelet aggregation
inhibitor, renin-angiotensin system modifier; 0 = none of
them) as a proxy of comorbidities.
Results
Characteristics of the family physicians
Most of the 270 family physicians included in the study
were men (n = 204, 76%) and they were aged 52 ± 5 years
on average in 2006. The total number of patients in their
databases was 373,827 and 385,962 in 2006 and 2009,
respectively. The median number of patients per family
physician was 1467 (1st and 3rd quartiles: 1225–1603)
in 2006 and 1505 (1st and 3rd quartiles: 1289–1620) in
2009 (p < 0.001). The percentage of patients registered
as having diabetes was 4.9% (95% CI: 4.7; 5.1) in 2006
and it increased to 5.4% (95% CI: 5.1; 5.6) in 2009
(p < 0.001).
Characteristics of the diabetic patients
The number of patients with diabetes was 18,507 in
2006 and 20,744 in 2009, and the vast majority of them
(n = 16,862) were cared for by the same family physician
in both years. About half of the patients were men (53%)
and their mean age was 66.1 and 67.8 years in 2006 and
2009 respectively (Table 2). In 2006, 26% of the patients
were under oral antidiabetic therapy (mainly metformin).More than half were under lipid lowering, antiplatelet or
antidiuretic drugs. For all the drugs considered, there
was a substantial increase in the percentage of patients
treated in 2009 vs 2006 (Table 2) (all p < 0.001).
Data collection performance of the family physicians
In 2006 the proportion of family physicians with no data
recorded in their electronic databases ranged between
33%, for total cholesterol measurement, to 93%, for foot
examination (Table 3). In 2009 the data collection im-
proved for all the indicators and the family physicians
with ≥50% or ≥75% of their patients with recorded data
increased significantly for 5 and 3 of the 12 indicators,
respectively.
A similar picture emerged when considering the family
physicians as a single group (Table 4). In 2006, the
proportion of patients with data on the indicators ranged
between 0.2% (foot examination) and 30.6% (total choles-
terol). Both the crude and adjusted analyses showed an
increase in all the indicators, with the exception of blood
pressure (≥4 registrations/year), which showed a signifi-
cant 9% decrease (adjusted RR = 0.91; 95% CI: 0.85, 0.98)
(Table 4). In the adjusted analysis, the relative change in
performance for the other indicators ranged between a
17% increase for BMI registration (RR = 1.17; 95% CI:
1.14, 1.21) to a four-fold increase for foot examination
(RR = 4.87; 95% CI: 2.97, 7.99).
Despite these large relative improvements, the proportion
of patients with data on the indicators in 2009 was still low
from an absolute point of view (between 0.9%, for foot
examination, and 42.1%, for total cholesterol). The percent-
age of patients with no indicators recorded was 42% in 2006
and it decreased to 32% in 2009 (Fig. 1). The percentage of
Table 3 Percentage of the 270 general practitioners (family physicians) who had 0%, ≥50% or ≥75% of their patients with diabetes
having data recorded for each of the 12 performance indicators in 2006 and 2009
Performance indicators Percentage of the family physicians
with 0% of their patients with data
Percentage of the family physicians with
≥50% of their patients with data
Percentage of the family physicians with
≥75% of their patients with data
2006 2009 2006 2009 2006 2009
Blood pressureb 49 38*** 0 0 0 0
BMIa 35 19*** 17 20 6 6
Smoking habitsa 67 57** 1 1 1 1
Total cholesterola 33 13*** 24 44*** 3 7*
LDL cholesterola 47 35*** 6 10** 0 0
Microalbuminuriaa 56 37*** 2 10*** 0 0
Creatininea 36 15*** 24 42*** 2 7**
Creatinine clearancea 76 47*** 0 0 0 0
Glycated haemoglobinb 72 45*** 0 0 0 0
Foot examinationa 93 74*** 0 0 0 0
Eye examinationa 35 9*** 0 0 0 0
Urine testa 38 17*** 17 35*** 2 5*
BMI body mass index, LDL low-density lipoprotein
a≥ 1 registration/year
b≥ 4 registrations/year
*,**,*** p for the comparison of proportions between years <0.05, <0.01, <0.001
Vaona et al. BMC Health Services Research  (2017) 17:565 Page 5 of 8patients with ≥5 indicators recorded was 9% in 2006 and
17% in 2009, but no diabetic patient had data for more than
10 indicators either in 2006 or 2009.
Quality of diabetes care
Since we had no measured values for MA, patients
who had performed the exam in the last year were
assigned an intermediate score of 5, as done by theTable 4 Number (percentage) of patients with diabetes having data
relative increase (relative risk, RR, with 95% CI) in the proportion of p
Performance indicator 2006 (N = 18,507)
n (%)
a Blood pressureb 1267 (6.8%)
b BMIa 4665 (25.2%)
c Smoking habitsa 730 (3.9%)
d Total cholesterola 5664 (30.6%)
e LDLa 2427 (13.1%)
f Microalbuminuriaa 1093 (5.9%)
g Creatininea 5482 (29.6%)
h Creatinine clearancea 173 (0.9%)
i Glycated haemoglobinb 200 (1.1%)
j Foot examinationa 32 (0.2%)
k Eye examinationa 2148 (11.6%)
l Urine testa 4830 (26.1%)
BMI body mass index, LDL low-density lipoprotein
a≥ 1 registration/year
b≥ 4 registrations/year
cAdjusted for patient’s sex, age, antidiabetic therapy, other therapydevelopers of the score [3], while the other patients
were set to missing. An assessment of quality of care
was possible for 14,480 (78%) patients in 2006 and
14,162 (68%) patients in 2009. The Q-score slightly in-
creased in 2009 (mean ± SD, 21.3 ± 3.6) with respect
to 2006 (20.7 ± 3.0) (p < 0.001). However, the large
majority of patients had a score ≤ 20 (85% in 2006, vs.
76% in 2009) (Additional file 1: Table S2).recorded for each of the 12 indicators in 2006 and 2009, and
atients with recorded data in 2009 with respect to 2006
2009 (N = 20,744) 2009 vs. 2006 2009 vs. 2006
n (%) crude
RR (95% CI)
adjustedc
RR (95% CI)
1470 (7.1%) 1.04 (0.97, 1.12) 0.91 (0.85, 0.98)
6126 (29.5%) 1.27 (1.23, 1.32) 1.17 (1.14, 1.21)
1034 (5.0%) 1.34 (1.21, 1.47) 1.25 (1.14, 1.37)
8726 (42.1%) 1.37 (1.33, 1.41) 1.27 (1.23, 1.30)
3829 (18.5%) 1.37 (1.30, 1.44) 1.21 (1.16, 1.27)
3438 (16.6%) 2.69 (2.41, 3.02) 2.33 (2.11, 2.57)
8376 (40.4%) 1.36 (1.31, 1.40) 1.26 (1.22, 1.29)
623 (3.0%) 2.90 (2.40, 3.51) 2.27 (1.90, 2.71)
453 (2.2%) 2.03 (1.70, 2.42) 1.60 (1.34, 1.90)
194 (0.9%) 6.18 (3.70, 10.33) 4.87 (2.97, 7.99)
3593 (17.3%) 1.53 (1.45, 1.62) 1.30 (1.24, 1.37)
7461 (36.0%) 1.36 (1.32, 1.41) 1.28 (1.24, 1.32)
01
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Fig. 1 Distribution of the patients with diabetes according to the number of indicators recorded in 2006 and 2009
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This study reports on data collection and quality of care for
diabetes in family medicine in the area of Verona, located in
the Veneto region of Italy, which is considered a benchmark
region for quality and efficiency of care from the national
Ministry of Health http://www.sanita24.ilsole24ore.
com/pdf2010/Editrice/ILSOLE24ORE/QUOTIDIANO_
SANITA/Online/_Oggetti_Correlati/Documenti/2017/02/02/
NUOVO_BENCHMARK.pdf?uuid=AEaAZHM. https://
www.regione.veneto.it/web/guest/comunicati-stampa/detta
glio-comunicati?_spp_detailId=3091057. http://www.sa
nita24.ilsole24ore.com/art/dal-governo/2017-02-02/mar
che-veneto-e-umbria-rosa-benchmark-181646.php?uuid
=AEYX7tM. We found that the proportion of patients
registered as having diabetes was 4.9% and 5.4% in 2006
and 2009 respectively, in agreement with the prevalence
rates estimated in other studies in the same area [5, 12, 13].
Our analyses seem to show an improvement in data
collection of patients with diabetes over the study
period. We detected an increase in the proportion of
family physicians with ≥50% and ≥75% of their patients
with available data on the indicators; when considering
the family physicians as a single group, we found a signifi-
cant increase in data collection for all the performance indi-
cators, with the exception of blood pressure recording
(maybe due to the recommendation to opt for home meas-
urement). All these improvements could be explained by a
better recording style due to the data consistency and
quality checks performed after the connection with the
databank (occurred in 2008) but they could also be
explained as the effect of educational programs or secular
trends.
Despite these improvements, it is remarkable that, in
absolute terms, the performance was still unsatisfactory
in both years on all the indicators. A comparison withother data from Italy and from different countries (for
the closest periods available) suggests that data collection
in Italian family medicine was lagging behind international
benchmarks (Table 1). In our study foot examination was
the indicator with the worst performance: it was recorded
just in 0.2% and 0.9% of the patients in 2006 and 2009
respectively. Performance for this indicator was 2% in the
Ascoli benchmark for 2004 [8], while it was 72% and 78%
in the UK in the 2006–7 and 2007–8 Diabetes National
Audit, respectively [7]. We found that eye examination
was carried out in 11.6% and 17.3% of the patients in 2006
and 2009 respectively, which is quite low compared to the
Ascoli 2004 benchmark (25%) [8], to the Health Search
national benchmark for 2006 and 2009 (43% and 42%
respectively) [10], and especially to the UK benchmark for
2006–7 and 2007–8 (66% and 67% respectively) [7]. BMI
measurement was recorded in 25.2% and 29.5% of our
patients in 2006 and 2009, while the Italian Health Search
and UK benchmarks were 32.2–37.8% and 85–88%,
respectively [7, 10]. Blood pressure (2006: 6.8%, and 2009:
7.1%) and glycated haemoglobin measurements (2006:
1.1%, and 2009: 2.2%) also showed a poor performance.
Four registrations/year were required to fulfil these
demanding criteria and this probably contributed to the
negative results. We found a scattered and sparse perform-
ance also for the number of indicators recorded, which we
analysed as a marker of completeness of care (or “all-care
process” indicator [7]): the registration decreased as the
number of indicators considered increased.
This unsatisfactory level of performance and the gap
compared to the international benchmarks are hard to
explain with a lack of performance of individual family
physicians, and we believe that health care organization
is likely to play a relevant role [17]. To the authors’
knowledge, the vast majority of Italian family physicians
Vaona et al. BMC Health Services Research  (2017) 17:565 Page 7 of 8work without supporting staff, medical assistants and
nurses. The observed low global performance may be a
consequence of poor teamwork organization and clinical
work overload, because resources may be inadequate
especially when the number of patients with identified
type-2 diabetes increases, taking family physicians to a
plateau of their capacity to follow up an increasing
number of patients.
In the interpretation of our findings it is also necessary
to consider that the effectiveness of electronic health
record-based management of diabetes have been demon-
strated primarily with process measures and selected
intermediate outcomes, such as glycated haemoglobin
and LDL levels, rather than clinical outcomes [18] but it
is reasonable to believe that improvement of care strictly
depends on the availability and quality of data [19]. In
our study an available record for an indicator does not
necessarily mean that its measured value is at target. For
these reasons, it is relevant to highlight that the analysis
of the validated Q-score confirms that the quality of
diabetes clinical management is largely improvable. Ac-
cording to the Q-score, even if the proportion of pa-
tients with a low quality of care (Q-score ≤ 20) was
slightly lower in 2009 than in 2006, most patients with
diabetes were at increased risk of cardiovascular events
and less than one patient out of four was receiving a
good quality of care in 2009.
This study has several limitations. First, the data refer
to several years ago. To our knowledge, however, this is
the first study performed in Italy on an unselected
sample of Italian family physicians. A central databank
collected data from all the family physicians who were
members of the FIMMG Union, which corresponded to
approximately 42% of all the family physicians working
in the study area. Since the Union membership is not
reasonably associated with professional performance,
our study design minimized the risk of self-selection bias
with respect to previous studies on voluntary physicians.
Thus, we believe that our study sample is representative
of the real-life management of diabetes in the study area
and period. Although the data are not recent, no major
widespread changes in the organisation of family medicine
have been implemented in Italy since the study period: the
last National General Medical Service Contract was signed
in 2005 http://www.sisac.info/anteprimaNewsHome.do?ti
po=WEB&idArea=201011221610481056&idNews=201012
212330479102&tit=&cat=&ddal=&dal=09/05/2017. http://
www.sisac.info/elencoNewsArea.do?rproprietario=2010122
11450435842&rrubrica=0&rdataaccordo=&operazione=ric
erca&dataDal=&idArea=201012211450435842&idPagina=
1&colOrderBy=tnews_versioni.news_titolo&order=asc&ri
cercaTitolo=&numberOfRecordsPerPage=10. Sparse edu-
cational interventions might have improved data recording
quality only modestly. Thus, the level of performance offamily physicians is unlikely to have changed significantly
since the study period. All the indicators selected were
included in the following update of the NICE clinical guide-
lines [20].
A second limitation is that we could only report on
data collection but we were not able to analyse the
measured values of the selected indicators, because meas-
urement data were patchy. Third, because of a lack of inte-
gration between primary and secondary health care levels,
we are unable to distinguish between poor clinical manage-
ment and missed registration of measurements or examina-
tions. Doctors could have omitted to record some of their
patients’ medical data that were already available in hospital
databases (one third of the patients attended diabetes
centres). Fourth, our disease definition was operational and
pragmatic, formulated by family physicians for working
purposes and it did not necessarily fit the guidelines defin-
ition. However, using data from another study on diabetes
in Legnago (province of Verona) in 2009, we found that
1745 out of 2127 (82%) subjects defined as having diabetes
by a similar disease definition were also identified on the
basis of administrative data (disease exemptions, admission
to diabetologic services, or purchase of antidiabetic drugs
or glucose test strips) [5]. Also, we acknowledge that our
disease definition could not disentangle between type-1 and
type-2 diabetes, but patients with type-1 diabetes are a
minority (5%) of the total population with diabetes and the
same definition was used to extract patients for both years.
Finally, the Q-score was calculated only for a part of the
patients with available data.
Conclusions
Data collection and quality of primary care for diabetes
improved between 2006 and 2009 but they were still
unsatisfactory in comparison with international benchmarks.
Structural interventions in the organization of family
medicine, which have not been implemented since the
study period, should be prioritised in Italy in order to
improve the management of patients with diabetes.
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